 |
PDBsum entry 6ac7
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nucleic Acids Res
47:1564-1572
(2019)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of a (3+1) hybrid G-quadruplex in the PARP1 promoter.
|
|
A.Sengar,
J.J.Vandana,
V.S.Chambers,
M.Di Antonio,
F.R.Winnerdy,
S.Balasubramanian,
A.T.Phan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Poly (ADP-ribose) polymerase 1 (PARP1) has emerged as an attractive target for
cancer therapy due to its key role in DNA repair processes. Inhibition of PARP1
in BRCA-mutated cancers has been observed to be clinically beneficial. Recent
genome-mapping experiments have identified a non-canonical G-quadruplex-forming
sequence containing bulges within the PARP1 promoter. Structural features, like
bulges, provide opportunities for selective chemical targeting of the
non-canonical G-quadruplex structure within the PARP1 promoter, which could
serve as an alternative therapeutic approach for the regulation of PARP1
expression. Here we report the G-quadruplex structure formed by a 23-nucleotide
G-rich sequence in the PARP1 promoter. Our study revealed a three-layered
intramolecular (3+1) hybrid G-quadruplex scaffold, in which three strands are
oriented in one direction and the fourth in the opposite direction. This
structure exhibits unique structural features such as an adenine bulge and a
G·G·T base triple capping structure formed between the central edgewise loop,
propeller loop and 5' flanking terminal. Given the highly important role of
PARP1 in DNA repair and cancer intervention, this structure presents an
attractive opportunity to explore the therapeutic potential of PARP1 inhibition
via G-quadruplex DNA targeting.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |